Meta-Analysis
Copyright ©The Author(s) 2025.
World J Clin Oncol. May 24, 2025; 16(5): 105881
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.105881
Table 1 Overview of studies assessing outcomes of liver resection vs ablation in hepatocellular carcinoma
Ref.
Study type
Pre-PSM sample size
Post-PSM sample size
Subgroups
Subgroup type
Bai et al[10]Retrospective comparative study21971346YesMicrovascular invasion risk
Chong et al[11]Retrospective comparative study214118No
Chua et al[12]Retrospective comparative study219104No
Gory et al[13]Retrospective comparative study146YesTumor size (< 3 cm; < 5 cm)
He et al[14]Retrospective comparative study435259No
Hsiao et al[15]Retrospective comparative study387No
Kim et al[16]Retrospective comparative study365122YesAFP level > 100 ng/mL (yes; no)
Lai et al[17]Retrospective comparative study94YesAge (< 60 years; > 60 years)
Liu et al[19]Retrospective comparative study836600YesRisk of recurrence (high; low)
Liu et al[18]Retrospective comparative study237158No
Lu et al[20]Retrospective comparative study332240YesMilan criteria (yes; no) and recurrence within 2 years (yes; no)
Ng et al[21]Randomized clinical trial218No
Qiu et al[22]Retrospective comparative study259154No
Song et al[24]Retrospective comparative study156YesTumor size (< 2 cm; 2-4 cm)
Song et al[23]Randomized clinical trial150No
Takayasu et al[25]Retrospective comparative study853732No
Vitale et al[26]Retrospective comparative study720693No
Wang et al[27]Retrospective comparative study672420YesAge (60-64 years; 65-72 years; > 73 years)
Wei et al[28]Retrospective comparative study382YesPre-operatorial imaging traits
Xia et al[29]Randomized clinical trial217YesTumor size (< 3 cm; > 3 cm) and AFP > 200 ng/mL (yes; no)
Ye et al[30]Retrospective comparative study388308YesTumor size (3-4 cm; 4-5 cm)
Zeng et al[31]Retrospective comparative study16321142YesTumor size (0-2 cm; 2-5 cm; > 5 cm) and age (< 65 years; > 65 years)
Zhong et al[32]Retrospective comparative study847454No